Perrigo Co. shares tumbled Monday as the company slashed its guidance for the year while announcing the departure of its Chief Executive Joseph Papa, who is moving to lead Valeant Pharmaceuticals International Inc.
The company, principally a maker of store-brand versions of cold and allergy medicines, now expects adjusted earnings to be between $8.20 and $8.60 a share, down sharply from its previous guidance for $9.50 to $9.80 a share.
Shares of the company slid 14% to $104.83 in midday trading.
My post is for Your Eyes only and my entertainment